While the majority of cases are transient and resolve within weeks, a substantial proportion (up to 25%) progress to persistent hypoparathyroidism, defined by sustained reductions in parathyroid hormone (PTH) and serum calcium levels beyond 6–12 months after surgery1,2,4,5. The gene discussed is PTH; the disease is hypoparathyroidism.